Health care startups that raised Series B
Source: FundingWatcher. Data as of 4 September 2026.
2,747
Companies
$71.6B
Last round total
100
Rows shown
4 September 2026
Data as of
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Faro AI | Series B | $37.3M | 2026-08-26 | La Jolla | Artificial intelligence |
| 2 | MileBot Robotics | Series B | $14.9M | 2026-08-26 | Shenzhen | Artificial intelligence |
| 3 | Arintra | Series B | $25.0M | 2026-08-21 | Austin | Artificial intelligence |
| 4 | Xiaocheng Changnu | Series B | $14.5M | 2026-08-21 | Tianjin | Fintech |
| 5 | Pixelgen Technologies | Series B | $15.5M | 2026-08-20 | Stockholm | Biotech |
| 6 | Butterfly Learnings | Series B | $6.8M | 2026-08-19 | Thane | Health care |
| 7 | Georgiamune | Series B | $92.7M | 2026-08-17 | Gaithersburg | Biotech |
| 8 | Leadinno Medical Valley | Series B | $29.7M | 2026-08-17 | Beijing | Health care |
| 9 | Khartis Therapeutics | Series B | $50.0M | 2026-08-13 | San Diego | Biotech |
| 10 | Hongxin Biology | Series B | $14.0M | 2026-08-13 | Shenzhen | Biotech |
| 11 | InduPro | Series B | $77.0M | 2026-08-12 | Seattle | Biotech |
| 12 | Amplifica | Series B | $26.0M | 2026-08-12 | San Diego | Biotech |
| 13 | Vaderis Therapeutics | Series B | $152.0M | 2026-08-11 | Basel | Biotech |
| 14 | Flagler Health | Series B | $50.0M | 2026-08-11 | New York | Biotech |
| 15 | Aureka Biotechnologies | Series B | $100.0M | 2026-08-10 | Laguna Hills | Artificial intelligence |
| 16 | Notable Systems | Series B | $18.1M | 2026-08-10 | Denver | Artificial intelligence |
| 17 | Awexome Ray | Series B | $5.3M | 2026-08-10 | Seongnam | Health care |
| 18 | Meduloc | Series B | $4.0M | 2026-08-06 | Del Mar | Health care |
| 19 | Expedition Therapeutics | Series B | $115.0M | 2026-08-05 | San Francisco | Biotech |
| 20 | Mironid | Series B | $45.9M | 2026-08-05 | Newhouse | Biotech |
| 21 | ADVATEC | Series B | $1.0M | 2026-08-05 | Shibuya | Artificial intelligence |
| 22 | QuantHealth | Series B | $45.0M | 2026-08-04 | Tel Aviv | Artificial intelligence |
| 23 | Wellinks (formerly Convexity Scientific) | Series B | $10.0M | 2026-08-04 | New Haven | Health care |
| 24 | Health Plus | Series B | 2026-08-03 | Beijing | Fintech | |
| 25 | MediQStar | Series B | 2026-08-03 | Seongnam | Artificial intelligence | |
| 26 | Qureight | Series B | $20.0M | 2026-07-29 | Cambridge | Artificial intelligence |
| 27 | Claris Biotherapeutics | Series B | $118.0M | 2026-07-28 | Jersey City | Biotech |
| 28 | SenseTime | Series B | $100.0M | 2026-07-28 | Shanghai | Artificial intelligence |
| 29 | Epitel | Series B | $26.0M | 2026-07-28 | Salt Lake City | Artificial intelligence |
| 30 | Layerwave Bio | Series B | $13.8M | 2026-07-28 | Daxing | Biotech |
| 31 | Crystalys Therapeutics | Series B | $130.0M | 2026-07-22 | San Diego | Biotech |
| 32 | Hilo by Aktiia | Series B | $19.0M | 2026-07-22 | Neuchâtel | Artificial intelligence |
| 33 | Hilo | Series B | $19.0M | 2026-07-21 | Neuchâtel | Health care |
| 34 | RapidPulse | Series B | $48.0M | 2026-07-16 | Miami | Health care |
| 35 | Bunkerhill Health | Series B | $25.0M | 2026-07-16 | Palo Alto | Artificial intelligence |
| 36 | Draig Therapeutics | Series B | $65.0M | 2026-07-14 | Cardiff | Biotech |
| 37 | Illuminare Biotechnologies | Series B | $2.4M | 2026-07-14 | Princeton | Biotech |
| 38 | Huaxia Yuan Group | Series B | 2026-07-14 | Minhang | Biotech | |
| 39 | MindRank AI | Series B | $52.0M | 2026-07-08 | Shanghai | Artificial intelligence |
| 40 | Sonosemi Medical | Series B | $27.3M | 2026-07-08 | Shenzhen | Health care |
| 41 | Pediatrica | Series B | $28.0M | 2026-07-07 | Coral Gables | Health care |
| 42 | Handspring Health | Series B | $19.0M | 2026-07-07 | Newark | Health care |
| 43 | Kuehnle Agrosystems | Series B | $3.0M | 2026-07-06 | Honolulu | Biotech |
| 44 | BLXCKSTONE | Series B | $10.0M | 2026-07-04 | Beverly Hills | Fintech |
| 45 | Pyrotech | Series B | 2026-07-03 | Changping | Biotech | |
| 46 | Emoha Elder Care | Series B | $8.9M | 2026-07-02 | Haryana | Health care |
| 47 | LASO Biotech | Series B | $14.0M | 2026-07-01 | Beijing | Health care |
| 48 | Materna Medical | Series B | $5.0M | 2026-07-01 | Mountain View | Health care |
| 49 | Inocras | Series B | $20K | 2026-07-01 | San Diego | Artificial intelligence |
| 50 | Xenter | Series B | $58.2M | 2026-06-30 | Draper | Hardware |
| 51 | Neusignal Therapeutics | Series B | $32.8M | 2026-06-30 | Tokyo | Biotech |
| 52 | The Indus Valley | Series B | $17.0M | 2026-06-30 | Chennai | Commerce |
| 53 | Etern | Series B | 2026-06-30 | Shanghai | Biotech | |
| 54 | Oblenio Bio | Series B | $62.0M | 2026-06-25 | Oakland | Biotech |
| 55 | Ollin Biosciences | Series B | $330.0M | 2026-06-24 | Austin | Biotech |
| 56 | xCures | Series B | $46.0M | 2026-06-24 | Oakland | Artificial intelligence |
| 57 | MyoGene Life Sciences | Series B | 2026-06-24 | Shenzhen | Health care | |
| 58 | Osanni Bio | Series B | $190.0M | 2026-06-23 | San Francisco | Biotech |
| 59 | CroíValve | Series B | $20.0M | 2026-06-23 | Dublin | Health care |
| 60 | Dentlink | Series B | $7.8M | 2026-06-23 | Mapo | Health care |
| 61 | Nansu Technology | Series B | 2026-06-23 | Hangzhou | Health care | |
| 62 | Nura Bio | Series B | $73.8M | 2026-06-22 | South San Francisco | Biotech |
| 63 | Sol-ti | Series B | $30.3M | 2026-06-22 | San Diego | Health care |
| 64 | Vanna Health | Series B | $17.0M | 2026-06-22 | San Francisco | Health care |
| 65 | Cour Pharmaceuticals Development | Series B | $50.0M | 2026-06-18 | Skokie | Biotech |
| 66 | Connie Health | Series B | $40.0M | 2026-06-18 | Boston | Health care |
| 67 | TruNativ | Series B | $30.0M | 2026-06-16 | Mumbai | Commerce |
| 68 | FNCT Biotech | Series B | $14.0M | 2026-06-16 | Seoul | Biotech |
| 69 | Plco | Series B | $2.7M | 2026-06-16 | Seocho | Health care |
| 70 | HMNC Brain Health | Series B | $50.0M | 2026-06-15 | München | Biotech |
| 71 | Huanying Medical | Series B | 2026-06-15 | Shenzhen | Health care | |
| 72 | Zumutor Biologics | Series B | $7.3M | 2026-06-13 | Woburn | Biotech |
| 73 | SonoThera | Series B | $125.0M | 2026-06-10 | South San Francisco | Biotech |
| 74 | City Therapeutics | Series B | $99.5M | 2026-06-08 | Cambridge | Biotech |
| 75 | Immuneel Therapeutics | Series B | $10.5M | 2026-06-08 | Bengaluru | Health care |
| 76 | PROMEDIUS | Series B | $14.0M | 2026-06-05 | Seoul | Artificial intelligence |
| 77 | Ona Therapeutics | Series B | $86.6M | 2026-06-04 | Barcelona | Biotech |
| 78 | X-MAGTECH | Series B | $14.8M | 2026-06-04 | Haidian | Health care |
| 79 | ARINCARE | Series B | 2026-06-04 | Bangkok | Health care | |
| 80 | California Naturals | Series B | $21.0M | 2026-06-03 | Los Angeles | Health care |
| 81 | Contraline | Series B | $92.5M | 2026-06-02 | Charlottesville | Biotech |
| 82 | Advanced NanoTherapies | Series B | $31.0M | 2026-06-02 | Los Gatos | Health care |
| 83 | HemaCell | Series B | $14.8M | 2026-06-02 | Suzhou | Biotech |
| 84 | Menovex | Series B | $14.8M | 2026-06-02 | Shenzhen | Health care |
| 85 | Rythm Health | Series B | $31.5M | 2026-06-01 | San Francisco | Health care |
| 86 | Anveshan | Series B | $12.7M | 2026-05-29 | Bengaluru | Health care |
| 87 | Nuclidium | Series B | $33.6M | 2026-05-28 | Basel | Health care |
| 88 | Triomics | Series B | $22.0M | 2026-05-27 | San Francisco | Artificial intelligence |
| 89 | ROBO Medical | Series B | 2026-05-25 | Shenzhen | Education | |
| 90 | Furong Biotech | Series B | $14.7M | 2026-05-20 | Suzhou | Biotech |
| 91 | Bivision | Series B | $58.8M | 2026-05-18 | Shanghai | Biotech |
| 92 | Hypershell | Series B | $50.0M | 2026-05-18 | Shenzhen | Artificial intelligence |
| 93 | WIRobotics | Series B | $63.5M | 2026-05-15 | Yongin | Hardware |
| 94 | CREATE Medicines | Series B | $122.0M | 2026-05-14 | Cambridge | Biotech |
| 95 | NVision Quantum Technologies | Series B | $38.0M | 2026-05-13 | Ulm | Biotech |
| 96 | AromeManpo | Series B | $14.4M | 2026-05-13 | Hangzhou | Commerce |
| 97 | 9amHealth | Series B | $26.0M | 2026-05-12 | Encinitas | Health care |
| 98 | Starna Therapeutics | Series B | $40.0M | 2026-05-11 | Suzhou | Biotech |
| 99 | Ruijiakang | Series B | $1.4M | 2026-05-11 | Wuhan | Biotech |
| 100 | LTZ Therapeutics | Series B | $38.0M | 2026-05-06 | San Francisco | Biotech |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,747.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | MGI Tech | Series B | $1.0B | 2020-05-28 | Shenzhen | Biotech |
| 2 | JD Health | Series B | $830.0M | 2020-08-17 | Beijing | Commerce |
| 3 | Botamedi | Series B | $657.8M | 2022-03-23 | Gangneung | Health care |
| 4 | Kailera Therapeutics | Series B | $600.0M | 2025-10-14 | Waltham | Biotech |
| 5 | Laronde | Series B | $440.0M | 2021-08-30 | Cambridge | Biotech |
| 6 | Ollin Biosciences | Series B | $330.0M | 2026-06-24 | Austin | Biotech |
| 7 | Cardurion Pharmaceuticals | Series B | $260.0M | 2024-07-16 | Boston | Biotech |
| 8 | Kardigan | Series B | $254.0M | 2025-10-14 | South San Francisco | Biotech |
| 9 | Mirador Therapeutics | Series B | $250.0M | 2026-01-12 | San Diego | Biotech |
| 10 | Wzhouhui.com | Series B | $245.4M | 2015-12-03 | Shenzhen | Commerce |
| 11 | AltruBio | Series B | $225.0M | 2024-05-21 | Los Altos | Biotech |
| 12 | Orna Therapeutics | Series B | $221.0M | 2022-08-16 | Cambridge | Biotech |
| 13 | Elemy | Series B | $219.0M | 2021-10-06 | San Francisco | Health care |
| 14 | Metsera | Series B | $215.0M | 2024-11-13 | New York | Biotech |
| 15 | Immunai | Series B | $215.0M | 2021-10-27 | New York | Artificial intelligence |
| 16 | Upstream Bio | Series B | $200.0M | 2023-06-08 | Waltham | Biotech |
| 17 | Sironax | Series B | $200.0M | 2022-08-02 | Beijing | Biotech |
| 18 | OrbusNeich Medical | Series B | $200.0M | 2021-08-30 | Sha Tin | Health care |
| 19 | Aera Therapeutics | Series B | $193.0M | 2023-02-16 | Boston | Biotech |
| 20 | Osanni Bio | Series B | $190.0M | 2026-06-23 | San Francisco | Biotech |
| 21 | Repertoire Immune Medicines | Series B | $189.0M | 2021-04-13 | Cambridge | Biotech |
| 22 | Valgen Medtech | Series B | $188.0M | 2021-05-06 | Hangzhou | Health care |
| 23 | Tune Therapeutics | Series B | $175.0M | 2025-01-12 | Durham | Biotech |
| 24 | Aktis Oncology | Series B | $175.0M | 2024-09-30 | Boston | Biotech |
| 25 | Capstan Therapeutics | Series B | $175.0M | 2024-03-20 | San Diego | Biotech |
| 26 | Mariana Oncology | Series B | $175.0M | 2023-09-07 | Watertown | Biotech |
| 27 | Asimov | Series B | $175.0M | 2023-01-05 | Boston | Artificial intelligence |
| 28 | Haihe Biopharma | Series B | $171.0M | 2020-07-24 | Shanghai | Biotech |
| 29 | Instil Bio | Series B | $170.2M | 2020-08-03 | Dallas | Biotech |
| 30 | Barinthus Biotherapeutics | Series B | $168.0M | 2021-03-17 | Harwell | Biotech |
| 31 | Awardco | Series B | $165.0M | 2025-05-20 | Lindon | Health care |
| 32 | Windward Bio | Series B | $165.0M | 2026-05-04 | Basel | Biotech |
| 33 | Nuvig Therapeutics | Series B | $161.0M | 2024-12-05 | Redwood City | Biotech |
| 34 | Genor Biopharma | Series B | $160.0M | 2020-06-01 | Beijing | Biotech |
| 35 | Engrail Therapeutics | Series B | $157.0M | 2024-03-19 | San Diego | Biotech |
| 36 | Quell Therapeutics | Series B | $156.0M | 2021-11-29 | London | Biotech |
| 37 | AIRNA | Series B | $155.0M | 2025-04-01 | Cambridge | Biotech |
| 38 | Meiwei Dental Group | Series B | $154.3M | 2021-07-16 | Jingan | Health care |
| 39 | Strand Therapeutics | Series B | $153.0M | 2025-08-03 | Cambridge | Biotech |
| 40 | Vaderis Therapeutics | Series B | $152.0M | 2026-08-11 | Basel | Biotech |
| 41 | Curative | Series B | $150.0M | 2025-11-28 | Austin | Fintech |
| 42 | Latigo Biotherapeutics | Series B | $150.0M | 2025-03-17 | Thousand Oaks | Biotech |
| 43 | Septerna | Series B | $150.0M | 2023-07-11 | San Francisco | Biotech |
| 44 | Alkeus Pharmaceuticals | Series B | $150.0M | 2023-06-05 | Cambridge | Biotech |
| 45 | Noah Medical | Series B | $150.0M | 2023-04-19 | San Carlos | Health care |
| 46 | MOMA Therapeutics | Series B | $150.0M | 2022-05-10 | Cambridge | Biotech |
| 47 | BostonGene | Series B | $150.0M | 2022-04-06 | Waltham | Biotech |
| 48 | JOINN Biologics | Series B | $150.0M | 2021-08-01 | Richmond | Biotech |
| 49 | WuXi Diagnostics | Series B | $150.0M | 2021-02-23 | Shanghai | Biotech |
| 50 | Visen Pharmaceuticals | Series B | $150.0M | 2021-01-08 | Shanghai | Biotech |
| 51 | Noema Pharma | Series B | $147.2M | 2024-12-11 | Basel | Biotech |
| 52 | Azafaros | Series B | $146.7M | 2025-05-13 | Leiden | Biotech |
| 53 | Zhaoke Ophthalmology Pharmaceutical | Series B | $145.0M | 2020-10-12 | Hong Kong | Biotech |
| 54 | Outpace Bio | Series B | $144.0M | 2024-08-01 | Seattle | Biotech |
| 55 | Abdera Therapeutics | Series B | $142.0M | 2023-04-20 | Vancouver | Biotech |
| 56 | AAVantgarde Bio | Series B | $141.0M | 2025-11-03 | Milano | Biotech |
| 57 | Avistone Pharmaceuticals | Series B | $140.7M | 2023-12-28 | Beijing | Biotech |
| 58 | Harbinger Health | Series B | $140.0M | 2023-09-28 | Cambridge | Artificial intelligence |
| 59 | Upstream Health | Series B | $140.0M | 2022-12-02 | Scunthorpe | Health care |
| 60 | UpStream Care | Series B | $140.0M | 2022-12-01 | Greensboro | Health care |
| 61 | RVAC Medicines | Series B | $140.0M | 2022-04-26 | Singapore | Biotech |
| 62 | Shoreline Biosciences | Series B | $140.0M | 2021-11-02 | La Jolla | Biotech |
| 63 | Sidewinder Therapeutics | Series B | $137.0M | 2026-04-08 | San Diego | Biotech |
| 64 | Preventice Solutions | Series B | $137.0M | 2020-07-15 | Houston | Health care |
| 65 | VelosBio | Series B | $137.0M | 2020-07-08 | San Diego | Biotech |
| 66 | Splice Bio | Series B | $135.0M | 2025-06-11 | Barcelona | Biotech |
| 67 | Chroma Medicine | Series B | $135.0M | 2023-02-28 | Cambridge | Biotech |
| 68 | Angle Health | Series B | $134.0M | 2025-12-03 | San Francisco | Artificial intelligence |
| 69 | Juno Therapeutics | Series B | $134.0M | 2014-08-05 | Seattle | Biotech |
| 70 | ARTBIO | Series B | $132.0M | 2025-07-29 | Cambridge | Biotech |
| 71 | Alterome Therapeutics | Series B | $132.0M | 2024-04-03 | San Diego | Biotech |
| 72 | Crystalys Therapeutics | Series B | $130.0M | 2026-07-22 | San Diego | Biotech |
| 73 | Protego Biopharma | Series B | $130.0M | 2025-12-01 | San Diego | Biotech |
| 74 | Harbor Health | Series B | $130.0M | 2025-09-09 | Austin | Health care |
| 75 | GlycoEra | Series B | $130.0M | 2025-05-27 | Wädenswil | Biotech |
| 76 | Halda Therapeutics | Series B | $126.0M | 2024-08-12 | New Haven | Biotech |
| 77 | SonoThera | Series B | $125.0M | 2026-06-10 | South San Francisco | Biotech |
| 78 | Ray Therapeutics | Series B | $125.0M | 2026-04-21 | San Diego | Biotech |
| 79 | Qualified Health | Series B | $125.0M | 2026-03-25 | San Carlos | Artificial intelligence |
| 80 | Diagonal Therapeutics | Series B | $125.0M | 2026-01-08 | Watertown | Biotech |
| 81 | ForSight Robotics | Series B | $125.0M | 2025-06-24 | Yoqne`am `illit | Hardware |
| 82 | Santa Ana Bio | Series B | $125.0M | 2024-06-13 | Alameda | Biotech |
| 83 | Design Therapeutics | Series B | $125.0M | 2021-01-27 | Solana Beach | Biotech |
| 84 | Flow Cannabis Co. | Series B | $125.0M | 2019-02-14 | San Francisco | Health care |
| 85 | Baraya Extended Care | Series B | $124.0M | 2025-07-15 | Riyadh | Health care |
| 86 | CREATE Medicines | Series B | $122.0M | 2026-05-14 | Cambridge | Biotech |
| 87 | Triana Biomedicines | Series B | $120.0M | 2025-12-03 | Lexington | Biotech |
| 88 | Pelage Pharmaceuticals | Series B | $120.0M | 2025-10-15 | Los Angeles | Health care |
| 89 | Prenuvo | Series B | $120.0M | 2025-02-13 | Vancouver | Health care |
| 90 | FIRE1 | Series B | $120.0M | 2025-01-07 | Dublin | Biotech |
| 91 | Idrx | Series B | $120.0M | 2024-08-07 | Cambridge | Biotech |
| 92 | Pheon Therapeutics | Series B | $120.0M | 2024-05-21 | London | Biotech |
| 93 | OriginCell | Series B | $120.0M | 2022-08-01 | Pudong | Biotech |
| 94 | Remilk | Series B | $120.0M | 2022-01-04 | Tel Aviv | Biotech |
| 95 | Forge Medical | Series B | $120.0M | 2021-04-29 | Lancaster | Hardware |
| 96 | Anaveon | Series B | $119.7M | 2021-12-16 | Bottmingen | Health care |
| 97 | Claris Biotherapeutics | Series B | $118.0M | 2026-07-28 | Jersey City | Biotech |
| 98 | Helio Health | Series B | $118.0M | 2021-07-15 | Irvine | Artificial intelligence |
| 99 | Amunix | Series B | $117.0M | 2021-03-04 | South San Francisco | Biotech |
| 100 | Expedition Therapeutics | Series B | $115.0M | 2026-08-05 | San Francisco | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,747.
By month
| Month | Companies |
|---|---|
| 2024-09 | 28 |
| 2024-10 | 30 |
| 2024-11 | 15 |
| 2024-12 | 23 |
| 2025-01 | 24 |
| 2025-02 | 22 |
| 2025-03 | 17 |
| 2025-04 | 31 |
| 2025-05 | 34 |
| 2025-06 | 17 |
| 2025-07 | 24 |
| 2025-08 | 27 |
| 2025-09 | 30 |
| 2025-10 | 36 |
| 2025-11 | 27 |
| 2025-12 | 31 |
| 2026-01 | 42 |
| 2026-02 | 23 |
| 2026-03 | 29 |
| 2026-04 | 20 |
| 2026-05 | 17 |
| 2026-06 | 36 |
| 2026-07 | 24 |
| 2026-08 | 25 |
Table 3. Health care startups that raised Series B by month of the round. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,747.
Country
| Country | Companies |
|---|---|
| United States | 1,289 |
| China | 654 |
| South Korea | 137 |
| United Kingdom | 96 |
| Japan | 59 |
| India | 57 |
| Israel | 52 |
| France | 51 |
| Germany | 50 |
| Switzerland | 49 |
| Canada | 40 |
| The Netherlands | 25 |
| Australia | 19 |
| Singapore | 19 |
| Ireland | 16 |
Table 4. Health care startups that raised Series B by country. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,747.
City
| City | Companies |
|---|---|
| Shanghai | 102 |
| Beijing | 92 |
| San Francisco | 91 |
| New York | 86 |
| Cambridge | 73 |
| San Diego | 59 |
| Boston | 58 |
| Seoul | 56 |
| Hangzhou | 54 |
| Shenzhen | 53 |
| Suzhou | 46 |
| London | 43 |
| Seattle | 34 |
| Guangzhou | 27 |
| Nanjing | 27 |
Table 5. Health care startups that raised Series B by city. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,747.
Sector
| Sector | Companies |
|---|---|
| Health care | 2,747 |
| Biotech | 1,221 |
| Software | 545 |
| Artificial intelligence | 211 |
| Hardware | 152 |
| Commerce | 89 |
| Fintech | 78 |
| Education | 36 |
| Cybersecurity | 10 |
| Energy | 6 |
Table 6. Health care startups that raised Series B by sector. Source: FundingWatcher. Data as of 4 September 2026. Base: 2,747.
Health care at other stages
Other sectors that raised Series B
software startups that raised Series B5,716
AI startups that raised Series B1,576
fintech startups that raised Series B1,502
commerce startups that raised Series B1,534
hardware startups that raised Series B2,352
biotech startups that raised Series B1,411
education startups that raised Series B485
cybersecurity startups that raised Series B643
energy startups that raised Series B508
Cite: FundingWatcher, 2,747 health care companies whose most recent round is Series B, 4 September 2026. https://fundingwatcher.com/startups/health-care/series-b/